Mark W. Feinberg, MD is a physician-scientist and academic leader at Harvard Medical School, where he is recognized for his contributions to cardiovascular medicine and vascular biology. His research focuses on the molecular mechanisms underlying atherosclerosis, inflammation, and endothelial cell function, with an emphasis on non-coding RNAs transcriptional regulation and lipid signaling pathways that drive cardiometabolic disease. Through his laboratory and collaborative work, Dr. Feinberg has advanced understanding of how vascular inflammation contributes to heart disease and related disorders. In addition to his research, Dr. Feinberg is dedicated to medical education and mentorship, training the next generation of physician-scientists. His work bridges basic science and clinical investigation, with the goal of translating discoveries in vascular biology into improved therapies for patients with cardiovascular disease.